Gregory W. Albers

Publications

• Clinical Outcomes Strongly Associated With the Degree of Reperfusion Achieved in Target Mismatch Patients: Pooled Data from the Diffusion and Perfusion Imaging Evaluation for Understanding Stroke Evolution Studies. Inoue M, Mlynash M, Straka M, Kemp S, Jovin TG, Tipirneni A, Hamilton SA, Marks MP, Bammer R, Lansberg MG, Albers GW. Stroke. 2013
• Early diffusion-weighted imaging and perfusion-weighted imaging lesion volumes forecast final infarct size in DEFUSE 2. Wheeler HM, Mlynash M, Inoue M, Tipirneni A, Liggins J, Zaharchuk G, Straka M, Kemp S, Bammer R, Lansberg MG, Albers GW. Stroke. 2013; 44 (3): 681-5
• Impact of Diffusion-Weighted Imaging Lesion Volume on the Success of Endovascular Reperfusion Therapy. Olivot JM, Mosimann PJ, Labreuche J, Inoue M, Meseguer E, Desilles JP, Rouchaud A, Klein IF, Straka M, Bammer R, Mlynash M, Amarenco P, Albers GW, Mazighi M. Stroke. 2013
• Impact of recanalization, reperfusion, and collateral flow on clinical efficacy. Albers GW, Stroke. 2013; 44 (6 Suppl 1): S11-2
• MR RESCUE: Is the Glass Half-Full or Half-Empty? Parsons MW, Albers GW. Stroke. 2013
• Selection of patients for intra-arterial therapy--authors' reply. Lansberg MG, Albers GW. Lancet Neurol. 2013; 12 (3): 225-6
• Arterial spin labeling imaging findings in transient ischemic attack patients: comparison with diffusion- and bolus perfusion-weighted imaging. Zaharchuk G, Olivot JM, Fischbein NJ, Bammer R, Straka M, Kleinman JT, Albers GW. Cerebrovasc Dis. 2012; 34 (3): 221-8
• Automated perfusion imaging for the evaluation of transient ischemic attack. Kleinman JT, Zaharchuk G, Mlynash M, Ogdie AA, Straka M, Lansberg MG, Schwartz NE, Kemp S, Bammer R, Albers GW, Olivot JM. Stroke. 2012; 43 (6): 1556-60
• Clinical assessment of standard and generalized autocalibrating partially parallel acquisition diffusion imaging: effects of reduction factor and spatial resolution. Andre JB, Zaharchuk G, Fischbein NJ, Augustin M, Skare S, Straka M, Rosenberg J, Lansberg MG, Kemp S, Wijman CA, Albers GW, Schwartz NE, Bammer R. AJNR Am J Neuroradiol. 2012; 33 (7): 1337-42
• Combined spin- and gradient-echo perfusion-weighted imaging. Schmiedeskamp H, Straka M, Newbould RD, Zaharchuk G, Andre JB, Olivot JM, Moseley ME, Albers GW, Bammer R. Magn Reson Med. 2012; 68 (1): 30-40
• Comparison of arterial spin labeling and bolus perfusion-weighted imaging for detecting mismatch in acute stroke. Zaharchuk G, El Mogy IS, Fischbein NJ, Albers GW. Stroke. 2012; 43 (7): 1843-8
• MRI profile and response to endovascular reperfusion after stroke (DEFUSE 2): a prospective cohort study. Lansberg MG, Straka M, Kemp S, Mlynash M, Wechsler LR, Jovin TG, Wilder MJ, Lutsep HL, Czartoski TJ, Bernstein RA, Chang CW, Warach S, Fazekas F, Inoue M, Tipirneni A, Hamilton SA, Zaharchuk G, Marks MP, Bammer R, Albers GW. Lancet Neurol. 2012; 11 (10): 860-7
• Patients with the malignant profile within 3 hours of symptom onset have very poor outcomes after intravenous tissue-type plasminogen activator therapy. Inoue M, Mlynash M, Straka M, Lansberg MG, Zaharchuk G, Bammer R, Albers GW. Stroke. 2012; 43 (9): 2494-6
• The infarct core is well represented by the acute diffusion lesion: sustained reversal is infrequent. Campbell BC, Purushotham A, Christensen S, Desmond PM, Nagakane Y, Parsons MW, Lansberg MG, Mlynash M, Straka M, De Silva DA, Olivot JM, Bammer R, Albers GW, Donnan GA, Davis SM. J Cereb Blood Flow Metab. 2012; 32 (1): 50-6
• Yield of CT perfusion for the evaluation of transient ischaemic attack. Kleinman JT, Mlynash M, Zaharchuk G, Ogdie AA, Straka M, Lansberg MG, Schwartz NE, Singh P, Kemp S, Bammer R, Albers GW, Olivot JM. Int J Stroke. 2012
• A 5-item scale to predict stroke outcome after cortical middle cerebral artery territory infarction: validation from results of the Diffusion and Perfusion Imaging Evaluation for Understanding Stroke Evolution (DEFUSE) Study. Vora NA, Shook SJ, Schumacher HC, Tievsky AL, Albers GW, Wechsler LR, Gupta R. Stroke. 2011; 42 (3): 645-9
• A topographic study of the evolution of the MR DWI/PWI mismatch pattern and its clinical impact: a study by the EPITHET and DEFUSE Investigators. Ogata T, Nagakane Y, Christensen S, Ma H, Campbell BC, Churilov L, Olivot JM, Desmond PM, Albers GW, Davis SM, Donnan GA. Stroke. 2011; 42 (6): 1596-601
• Diffusion-perfusion MRI for triaging transient ischemic attack and acute cerebrovascular syndromes. Olivot JM, Albers GW. Curr Opin Neurol. 2011; 24 (1): 44-9
• Early stroke risk and ABCD2 score performance in tissue- vs time-defined TIA: a multicenter study. Giles MF, Albers GW, Amarenco P, Arsava EM, Asimos AW, Ay H, Calvet D, Coutts SB, Cucchiara BL, Demchuk AM, Johnston SC, Kelly PJ, Kim AS, Labreuche J, Lavallee PC, Mas JL, Merwick A, Olivot JM, Purroy F, Rosamond WD, Sciolla R, Rothwell PM. Neurology. 2011; 77 (13): 1222-8
• Fluid-attenuated inversion recovery hyperintensity in acute ischemic stroke may not predict hemorrhagic transformation. Campbell BC, Costello C, Christensen S, Ebinger M, Parsons MW, Desmond PM, Barber PA, Butcher KS, Levi CR, De Silva DA, Lansberg MG, Mlynash M, Olivot JM, Straka M, Bammer R, Albers GW, Donnan GA, Davis SM. Cerebrovasc Dis. 2011; 32 (4): 401-5
• Greater effect of stroke thrombolysis in the presence of arterial obstruction. De Silva DA, Churilov L, Olivot JM, Christensen S, Lansberg MG, Mlynash M, Campbell BC, Desmond P, Straka M, Bammer R, Albers GW, Davis SM, Donnan GA. Ann Neurol. 2011; 70 (4): 601-5
• Guidelines for the prevention of stroke in patients with stroke or transient ischemic attack: a guideline for healthcare professionals from the american heart association/american stroke association. Furie KL, Kasner SE, Adams RJ, Albers GW, Bush RL, Fagan SC, Halperin JL, Johnston SC, Katzan I, Kernan WN, Mitchell PH, Ovbiagele B, Palesch YY, Sacco RL, Schwamm LH, Wassertheil-Smoller S, Turan TN, Wentworth D. Stroke. 2011; 42 (1): 227-76
• Heterogeneity in the penumbra. del Zoppo GJ, Sharp FR, Heiss WD, Albers GW. J Cereb Blood Flow Metab. 2011; 31 (9): 1836-51
• Improving the accuracy of perfusion imaging in acute ischemic stroke. Albers GW, Fisher M. Ann Neurol. 2011; 70 (3): 347-9
• MRI guides diagnostic approach for ischaemic stroke. Kumar MA, Vangala H, Tong DC, Campbell DM, Balgude A, Eyngorn I, Beraud AS, Olivot JM, Hsia AW, Bernstein RA, Wijman CA, Lansberg MG, Mlynash M, Hamilton S, Moseley ME, Albers GW. J Neurol Neurosurg Psychiatry. 2011; 82 (11): 1201-5
• National Stroke Association recommendations for systems of care for transient ischemic attack. Johnston SC, Albers GW, Gorelick PB, Cumbler E, Klingman J, Ross MA, Briggs M, Carlton J, Sloan EP, Vaince U. Ann Neurol. 2011; 69 (5): 872-7
• Postthrombolysis hemorrhage risk is affected by stroke assessment bias between hemispheres. Audebert HJ, Singer OC, Gotzler B, Vatankhah B, Boy S, Fiehler J, Lansberg MG, Albers GW, Kastrup A, Rovira A, Gass A, Rosso C, Derex L, Kim JS, Heuschmann P. Neurology. 2011; 76 (7): 629-36
• RAPID automated patient selection for reperfusion therapy: a pooled analysis of the Echoplanar Imaging Thrombolytic Evaluation Trial (EPITHET) and the Diffusion and Perfusion Imaging Evaluation for Understanding Stroke Evolution (DEFUSE) Study. Lansberg MG, Lee J, Christensen S, Straka M, De Silva DA, Mlynash M, Campbell BC, Bammer R, Olivot JM, Desmond P, Davis SM, Donnan GA, Albers GW. Stroke. 2011; 42 (6): 1608-14
• Refining the definition of the malignant profile: insights from the DEFUSE-EPITHET pooled data set. Mlynash M, Lansberg MG, De Silva DA, Lee J, Christensen S, Straka M, Campbell BC, Bammer R, Olivot JM, Desmond P, Donnan GA, Davis SM, Albers GW. Stroke. 2011; 42 (5): 1270-5
• Role of diffusion and perfusion MRI in selecting patients for reperfusion therapies. Grigoryan M, Tung CE, Albers GW. Neuroimaging Clin N Am. 2011; 21 (2): 247-57, ix-x
• Stroke Treatment Academic Industry Roundtable (STAIR) recommendations for maximizing the use of intravenous thrombolytics and expanding treatment options with intra-arterial and neuroprotective therapies. Albers GW, Goldstein LB, Hess DC, Wechsler LR, Furie KL, Gorelick PB, Hurn P, Liebeskind DS, Nogueira RG, Saver JL. Stroke. 2011; 42 (9): 2645-50
• Systemic augmentation of alphaB-crystallin provides therapeutic benefit twelve hours post-stroke onset via immune modulation. Arac A, Brownell SE, Rothbard JB, Chen C, Ko RM, Pereira MP, Albers GW, Steinman L, Steinberg GK. Proc Natl Acad Sci U S A. 2011; 108 (32): 13287-92
• Two aces: transient ischemic attack work-up as outpatient assessment of clinical evaluation and safety. Olivot JM, Wolford C, Castle J, Mlynash M, Schwartz NE, Lansberg MG, Kemp S, Albers GW. Stroke. 2011; 42 (7): 1839-43
• Addition of brain and carotid imaging to the ABCD² score to identify patients at early risk of stroke after transient ischaemic attack: a multicentre observational study. Merwick A, Albers GW, Amarenco P, Arsava EM, Ay H, Calvet D, Coutts SB, Cucchiara BL, Demchuk AM, Furie KL, Giles MF, Labreuche J, Lavallée PC, Mas JL, Olivot JM, Purroy F, Rothwell PM, Saver JL, Sheehan OC, Stack JP, Walsh C, Kelly PJ. Lancet Neurol. 2010; 9 (11): 1060-9
• Addition of brain infarction to the ABCD2 Score (ABCD2I): a collaborative analysis of unpublished data on 4574 patients. Giles MF, Albers GW, Amarenco P, Arsava MM, Asimos A, Ay H, Calvet D, Coutts S, Cucchiara BL, Demchuk AM, Johnston SC, Kelly PJ, Kim AS, Labreuche J, Lavallee PC, Mas JL, Merwick A, Olivot JM, Purroy F, Rosamond WD, Sciolla R, Rothwell PM. Stroke. 2010; 41 (9): 1907-13
• Agreement regarding diagnosis of transient ischemic attack fairly low among stroke-trained neurologists. Castle J, Mlynash M, Lee K, Caulfield AF, Wolford C, Kemp S, Hamilton S, Albers GW, Olivot JM. Stroke. 2010; 41 (7): 1367-70
• Capsular warning syndrome caused by middle cerebral artery stenosis. Lee J, Albers GW, Marks MP, Lansberg MG. J Neurol Sci. 2010; 296 (1-2): 115-20
• Combined arterial spin label and dynamic susceptibility contrast measurement of cerebral blood flow. Zaharchuk G, Straka M, Marks MP, Albers GW, Moseley ME, Bammer R. Magn Reson Med. 2010; 63 (6): 1548-56
• Dabigatran challenges warfarin's superiority for stroke prevention in atrial fibrillation. Schwartz NE, Albers GW. Stroke. 2010; 41 (6): 1307-9
• MRI profile of the perihematomal region in acute intracerebral hemorrhage. Olivot JM, Mlynash M, Kleinman JT, Straka M, Venkatasubramanian C, Bammer R, Moseley ME, Albers GW, Wijman CA. Stroke. 2010; 41 (11): 2681-3
• Mismatch-based delayed thrombolysis: a meta-analysis. Mishra NK, Albers GW, Davis SM, Donnan GA, Furlan AJ, Hacke W, Lees KR. Stroke. 2010; 41 (1): e25-33
• Real-time diffusion-perfusion mismatch analysis in acute stroke. Straka M, Albers GW, Bammer R. J Magn Reson Imaging. 2010; 32 (5): 1024-37
• Stroke: more protection for patients with atrial fibrillation. Albers GW, Lancet Neurol. 2010; 9 (1): 2-4
• Study design of the CLOSURE I Trial: a prospective, multicenter, randomized, controlled trial to evaluate the safety and efficacy of the STARFlex septal closure system versus best medical therapy in patients with stroke or transient ischemic attack due to presumed paradoxical embolism through a patent foramen ovale. Furlan AJ, Reisman M, Massaro J, Mauri L, Adams H, Albers GW, Felberg R, Herrmann H, Kar S, Landzberg M, Raizner A, Wechsler L. Stroke. 2010; 41 (12): 2872-83
• Time to treatment with intravenous alteplase and outcome in stroke: an updated pooled analysis of ECASS, ATLANTIS, NINDS, and EPITHET trials. Lees KR, Bluhmki E, von Kummer R, Brott TG, Toni D, Grotta JC, Albers GW, Kaste M, Marler JR, Hamilton SA, Tilley BC, Davis SM, Donnan GA, Hacke W, Allen K, Mau J, Meier D, del Zoppo G, De Silva DA, Butcher KS, Parsons MW, Barber PA, Levi C, Bladin C, Byrnes G. Lancet. 2010; 375 (9727): 1695-703
• Using advanced MRI techniques for patient selection before acute stroke therapy. Olivot JM, Albers GW. Curr Treat Options Cardiovasc Med. 2010; 12 (3): 230-9
• Clinical and radiographic natural history of cervical artery dissections. Schwartz NE, Vertinsky AT, Hirsch KG, Albers GW. J Stroke Cerebrovasc Dis. 2009 Nov-Dec; 18 (6): 416-23
• Acute strokes in the setting of a persistent primitive trigeminal artery. Schwartz NE, Albers GW. BMJ Case Rep. 2009: 2009 bcr2006111773
• Antithrombotic agents for stroke prevention. Schwartz NE, Diener HC, Albers GW. Handb Clin Neurol. 2009: 94 1277-94
• Challenges in childhood arterial ischaemic stroke. Massicotte MP, Bauman ME, Albers GW. Lancet Neurol. 2009; 8 (12): 1079-81
• Effectiveness and safety of transcranial laser therapy for acute ischemic stroke. Zivin JA, Albers GW, Bornstein N, Chippendale T, Dahlof B, Devlin T, Fisher M, Hacke W, Holt W, Ilic S, Kasner S, Lew R, Nash M, Perez J, Rymer M, Schellinger P, Schneider D, Schwab S, Veltkamp R, Walker M, Streeter J. Stroke. 2009; 40 (4): 1359-64
• Geography, structure, and evolution of diffusion and perfusion lesions in Diffusion and perfusion imaging Evaluation For Understanding Stroke Evolution (DEFUSE). Olivot JM, Mlynash M, Thijs VN, Purushotham A, Kemp S, Lansberg MG, Wechsler L, Gold GE, Bammer R, Marks MP, Albers GW. Stroke. 2009; 40 (10): 3245-51
• Hyperfibrinogenemia and functional outcome from acute ischemic stroke. del Zoppo GJ, Levy DE, Wasiewski WW, Pancioli AM, Demchuk AM, Trammel J, Demaerschalk BM, Kaste M, Albers GW, Ringelstein EB. Stroke. 2009; 40 (5): 1687-91
• Improving dynamic susceptibility contrast MRI measurement of quantitative cerebral blood flow using corrections for partial volume and nonlinear contrast relaxivity: A xenon computed tomographic comparative study. Zaharchuk G, Bammer R, Straka M, Newbould RD, Rosenberg J, Olivot JM, Mlynash M, Lansberg MG, Schwartz NE, Marks MM, Albers GW, Moseley ME. J Magn Reson Imaging. 2009; 30 (4): 743-52
• Neurological outcomes in patients with ischemic stroke receiving enoxaparin or heparin for venous thromboembolism prophylaxis: subanalysis of the Prevention of VTE after Acute Ischemic Stroke with LMWH (PREVAIL) study. Kase CS, Albers GW, Bladin C, Fieschi C, Gabbai AA, O'Riordan W, Pineo GF. Stroke. 2009; 40 (11): 3532-40
• Optimal Tmax threshold for predicting penumbral tissue in acute stroke. Olivot JM, Mlynash M, Thijs VN, Kemp S, Lansberg MG, Wechsler L, Bammer R, Marks MP, Albers GW. Stroke. 2009; 40 (2): 469-75
• Perfusion MRI (Tmax and MTT) correlation with xenon CT cerebral blood flow in stroke patients. Olivot JM, Mlynash M, Zaharchuk G, Straka M, Bammer R, Schwartz N, Lansberg MG, Moseley ME, Albers GW. Neurology. 2009; 72 (13): 1140-5
• Prognostic value of brain diffusion-weighted imaging after cardiac arrest. Wijman CA, Mlynash M, Caulfield AF, Hsia AW, Eyngorn I, Bammer R, Fischbein N, Albers GW, Moseley M. Ann Neurol. 2009; 65 (4): 394-402
• Relationships between cerebral perfusion and reversibility of acute diffusion lesions in DEFUSE: insights from RADAR. Olivot JM, Mlynash M, Thijs VN, Purushotham A, Kemp S, Lansberg MG, Wechsler L, Bammer R, Marks MP, Albers GW. Stroke. 2009; 40 (5): 1692-7
• Risk of symptomatic intracerebral hemorrhage in patients treated with intra-arterial thrombolysis. Singer OC, Berkefeld J, Lorenz MW, Fiehler J, Albers GW, Lansberg MG, Kastrup A, Rovira A, Liebeskind DS, Gass A, Rosso C, Derex L, Kim JS, Neumann-Haefelin T. Cerebrovasc Dis. 2009; 27 (4): 368-74
• Stroke Therapy Academic Industry Roundtable (STAIR) recommendations for extended window acute stroke therapy trials. Saver JL, Albers GW, Dunn B, Johnston KC, Fisher M. Stroke. 2009; 40 (7): 2594-600
• Use of MRI to estimate the therapeutic window in acute stroke: is perfusion-weighted imaging/diffusion-weighted imaging mismatch an EPITHET for salvageable ischemic brain tissue? Toth G, Albers GW. Stroke. 2009; 40 (1): 333-5
• Yield of combined perfusion and diffusion MR imaging in hemispheric TIA. Mlynash M, Olivot JM, Tong DC, Lansberg MG, Eyngorn I, Kemp S, Moseley ME, Albers GW. Neurology. 2009; 72 (13): 1127-33
• Optimal outcome measures for detecting clinical benefits of early reperfusion: insights from the DEFUSE Study. Kakuda W, Hamilton S, Thijs VN, Lansberg MG, Kemp S, Skalabrin E, Albers GW. J Stroke Cerebrovasc Dis. 2008 Jul-Aug; 17 (4): 235-40
• Acute stroke imaging research roadmap. Wintermark M, Albers GW, Alexandrov AV, Alger JR, Bammer R, Baron JC, Davis S, Demaerschalk BM, Derdeyn CP, Donnan GA, Eastwood JD, Fiebach JB, Fisher M, Furie KL, Goldmakher GV, Hacke W, Kidwell CS, Kloska SP, Köhrmann M, Koroshetz W, Lee TY, Lees KR, Lev MH, Liebeskind DS, Ostergaard L, Powers WJ, Provenzale J, Schellinger P, Silbergleit R, Sorensen AG, Wardlaw J, Wu O, Warach S. AJNR Am J Neuroradiol. 2008; 29 (5): e23-30
• Antithrombotic and thrombolytic therapy for ischemic stroke: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines (8th Edition). Albers GW, Amarenco P, Easton JD, Sacco RL, Teal P. Chest. 2008; 133 (6 Suppl): 630S-669S
• Antithrombotic and thrombolytic therapy: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines (8th Edition). Hirsh J, Guyatt G, Albers GW, Harrington R, Schünemann HJ, American College of Chest Physician. Chest. 2008; 133 (6 Suppl): 110S-112S
• Antithrombotic therapy in atrial fibrillation: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines (8th Edition). Singer DE, Albers GW, Dalen JE, Fang MC, Go AS, Halperin JL, Lip GY, Manning WJ. Chest. 2008; 133 (6 Suppl): 546S-592S
• Aspirin and extended-release dipyridamole versus clopidogrel for recurrent stroke. Sacco RL, Diener HC, Yusuf S, Cotton D, Ounpuu S, Lawton WA, Palesch Y, Martin RH, Albers GW, Bath P, Bornstein N, Chan BP, Chen ST, Cunha L, Dahlöf B, De Keyser J, Donnan GA, Estol C, Gorelick P, Gu V, Hermansson K, Hilbrich L, Kaste M, Lu C, Machnig T, Pais P, Roberts R, Skvortsova V, Teal P, Toni D, Vandermaelen C, Voigt T, Weber M, Yoon BW. N Engl J Med. 2008; 359 (12): 1238-51
• Comparison of multidetector CT angiography and MR imaging of cervical artery dissection. Vertinsky AT, Schwartz NE, Fischbein NJ, Rosenberg J, Albers GW, Zaharchuk G. AJNR Am J Neuroradiol. 2008; 29 (9): 1753-60
• Effect of ximelagatran and warfarin on stroke subtypes in atrial fibrillation. Teitelbaum JS, von Kummer R, Gjesdal K, Kristinsson A, Gahn G, Albers GW. Can J Neurol Sci. 2008; 35 (2): 160-5
• Effects of aspirin plus extended-release dipyridamole versus clopidogrel and telmisartan on disability and cognitive function after recurrent stroke in patients with ischaemic stroke in the Prevention Regimen for Effectively Avoiding Second Strokes (PRoFESS) trial: a double-blind, active and placebo-controlled study. Diener HC, Sacco RL, Yusuf S, Cotton D, Ounpuu S, Lawton WA, Palesch Y, Martin RH, Albers GW, Bath P, Bornstein N, Chan BP, Chen ST, Cunha L, Dahlöf B, De Keyser J, Donnan GA, Estol C, Gorelick P, Gu V, Hermansson K, Hilbrich L, Kaste M, Lu C, Machnig T, Pais P, Roberts R, Skvortsova V, Teal P, Toni D, VanderMaelen C, Voigt T, Weber M, Yoon BW. Lancet Neurol. 2008; 7 (10): 875-84
• Executive summary: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines (8th Edition). Hirsh J, Guyatt G, Albers GW, Harrington R, Schünemann HJ. Chest. 2008; 133 (6 Suppl): 71S-109S
• Optimal definition for PWI/DWI mismatch in acute ischemic stroke patients. Kakuda W, Lansberg MG, Thijs VN, Kemp SM, Bammer R, Wechsler LR, Moseley ME, Marks MP, Parks MP, Albers GW. J Cereb Blood Flow Metab. 2008; 28 (5): 887-91
• Patients with acute stroke treated with intravenous tPA 3-6 hours after stroke onset: correlations between MR angiography findings and perfusion- and diffusion-weighted imaging in the DEFUSE study. Marks MP, Olivot JM, Kemp S, Lansberg MG, Bammer R, Wechsler LR, Albers GW, Thijs V. Radiology. 2008; 249 (2): 614-23
• Rapid assessment and intervention at specialist outpatient clinics-time for a new standard in TIA care? Albers GW, Nat Clin Pract Neurol. 2008; 4 (4): 184-5
• Relationships between infarct growth, clinical outcome, and early recanalization in diffusion and perfusion imaging for understanding stroke evolution (DEFUSE). Olivot JM, Mlynash M, Thijs VN, Kemp S, Lansberg MG, Wechsler L, Schlaug G, Bammer R, Marks MP, Albers GW. Stroke. 2008; 39 (8): 2257-63
• Risk for symptomatic intracerebral hemorrhage after thrombolysis assessed by diffusion-weighted magnetic resonance imaging. Singer OC, Humpich MC, Fiehler J, Albers GW, Lansberg MG, Kastrup A, Rovira A, Liebeskind DS, Gass A, Rosso C, Derex L, Kim JS, Neumann-Haefelin T. Ann Neurol. 2008; 63 (1): 52-60
• Telmisartan to prevent recurrent stroke and cardiovascular events. Yusuf S, Diener HC, Sacco RL, Cotton D, Ounpuu S, Lawton WA, Palesch Y, Martin RH, Albers GW, Bath P, Bornstein N, Chan BP, Chen ST, Cunha L, Dahlöf B, De Keyser J, Donnan GA, Estol C, Gorelick P, Gu V, Hermansson K, Hilbrich L, Kaste M, Lu C, Machnig T, Pais P, Roberts R, Skvortsova V, Teal P, Toni D, VanderMaelen C, Voigt T, Weber M, Yoon BW. N Engl J Med. 2008; 359 (12): 1225-37
• The MRA-DWI mismatch identifies patients with stroke who are likely to benefit from reperfusion. Lansberg MG, Thijs VN, Bammer R, Olivot JM, Marks MP, Wechsler LR, Kemp S, Albers GW. Stroke. 2008; 39 (9): 2491-6
• Use of antiplatelet agents to prevent stroke: what is the role for combinations of medications? Schwartz NE, Albers GW. Curr Neurol Neurosci Rep. 2008; 8 (1): 29-34
• Bleeding risk analysis in stroke imaging before thromboLysis (BRASIL): pooled analysis of T2*-weighted magnetic resonance imaging data from 570 patients. Fiehler J, Albers GW, Boulanger JM, Derex L, Gass A, Hjort N, Kim JS, Liebeskind DS, Neumann-Haefelin T, Pedraza S, Rother J, Rothwell P, Rovira A, Schellinger PD, Trenkler J. Stroke. 2007; 38 (10): 2738-44
• Can the ESPRIT results end the antiplatelet battle between neurologists and cardiologists? Albers GW, Nat Clin Pract Cardiovasc Med. 2007; 4 (3): 118-9
• Clinical multishot DW-EPI through parallel imaging with considerations of susceptibility, motion, and noise. Skare S, Newbould RD, Clayton DB, Albers GW, Nagle S, Bammer R. Magn Reson Med. 2007; 57 (5): 881-90
• Comparison of outcomes among patients randomized to warfarin therapy according to anticoagulant control: results from SPORTIF III and V. White HD, Gruber M, Feyzi J, Kaatz S, Tse HF, Husted S, Albers GW. Arch Intern Med. 2007; 167 (3): 239-45
• Evaluation of the clinical-diffusion and perfusion-diffusion mismatch models in DEFUSE. Lansberg MG, Thijs VN, Hamilton S, Schlaug G, Bammer R, Kemp S, Albers GW. Stroke. 2007; 38 (6): 1826-30
• Identifying systematic errors in quantitative dynamic-susceptibility contrast perfusion imaging by high-resolution multi-echo parallel EPI. Jochimsen TH, Newbould RD, Skare ST, Clayton DB, Albers GW, Moseley ME, Bammer R. NMR Biomed. 2007; 20 (4): 429-38
• Intravenous alteplase for ischaemic stroke. Albers GW, Olivot JM. Lancet. 2007; 369 (9558): 249-50
• Is there a role for combinations of antiplatelet agents in stroke prevention? Schwartz NE, Albers GW. Curr Treat Options Neurol. 2007; 9 (6): 442-50
• Neurological picture. Acute strokes in the setting of a persistent primitive trigeminal artery. Schwartz NE, Albers GW. J Neurol Neurosurg Psychiatry. 2007; 78 (7): 745
• Perfusion mapping with multiecho multishot parallel imaging EPI. Newbould RD, Skare ST, Jochimsen TH, Alley MT, Moseley ME, Albers GW, Bammer R. Magn Reson Med. 2007; 58 (1): 70-81
• Risk factors of symptomatic intracerebral hemorrhage after tPA therapy for acute stroke. Lansberg MG, Thijs VN, Bammer R, Kemp S, Wijman CA, Marks MP, Albers GW. Stroke. 2007; 38 (8): 2275-8
• Secondary stroke prevention with ximelagatran versus warfarin in patients with atrial fibrillation: pooled analysis of SPORTIF III and V clinical trials. Akins PT, Feldman HA, Zoble RG, Newman D, Spitzer SG, Diener HC, Albers GW. Stroke. 2007; 38 (3): 874-80
• Symptomatic intracerebral hemorrhage following thrombolytic therapy for acute ischemic stroke: a review of the risk factors. Lansberg MG, Albers GW, Wijman CA. Cerebrovasc Dis. 2007; 24 (1): 1-10
• The efficacy and safety of enoxaparin versus unfractionated heparin for the prevention of venous thromboembolism after acute ischaemic stroke (PREVAIL Study): an open-label randomised comparison. Sherman DG, Albers GW, Bladin C, Fieschi C, Gabbai AA, Kase CS, O'Riordan W, Pineo GF. Lancet. 2007; 369 (9570): 1347-55
• Transient isolated vertigo secondary to an acute stroke of the cerebellar nodulus. Schwartz NE, Venkat C, Albers GW. Arch Neurol. 2007; 64 (6): 897-8
• Warfarin prevails for stroke prevention in atrial fibrillation--even in octogenarians. Albers GW, Lancet Neurol. 2007; 6 (10): 844-6
• Acute cerebrovascular syndrome: time for new terminology for acute brain ischemia. Albers GW, Nat Clin Pract Cardiovasc Med. 2006; 3 (10): 521
• Dose Escalation of Desmoteplase for Acute Ischemic Stroke (DEDAS): evidence of safety and efficacy 3 to 9 hours after stroke onset. Furlan AJ, Eyding D, Albers GW, Al-Rawi Y, Lees KR, Rowley HA, Sachara C, Soehngen M, Warach S, Hacke W. Stroke. 2006; 37 (5): 1227-31
• Guidelines for prevention of stroke in patients with ischemic stroke or transient ischemic attack: a statement for healthcare professionals from the American Heart Association/American Stroke Association Council on Stroke: co-sponsored by the Council on Cardiovascular Radiology and Intervention: the American Academy of Neurology affirms the value of this guideline. Sacco RL, Adams R, Albers G, Alberts MJ, Benavente O, Furie K, Goldstein LB, Gorelick P, Halperin J, Harbaugh R, Johnston SC, Katzan I, Kelly-Hayes M, Kenton EJ, Marks M, Schwamm LH, Tomsick T. Circulation. 2006; 113 (10): e409-49
• MRI characteristics of cerebral air embolism from a venous source. Caulfield AF, Lansberg MG, Marks MP, Albers GW, Wijman CA. Neurology. 2006; 66 (6): 945-6
• Magnetic resonance imaging profiles predict clinical response to early reperfusion: the diffusion and perfusion imaging evaluation for understanding stroke evolution (DEFUSE) study. Albers GW, Thijs VN, Wechsler L, Kemp S, Schlaug G, Skalabrin E, Bammer R, Kakuda W, Lansberg MG, Shuaib A, Coplin W, Hamilton S, Moseley M, Marks MP. Ann Neurol. 2006; 60 (5): 508-17
• National Stroke Association guidelines for the management of transient ischemic attacks. Johnston SC, Nguyen-Huynh MN, Schwarz ME, Fuller K, Williams CE, Josephson SA, Hankey GJ, Hart RG, Levine SR, Biller J, Brown RD, Sacco RL, Kappelle LJ, Koudstaal PJ, Bogousslavsky J, Caplan LR, van Gijn J, Algra A, Rothwell PM, Adams HP, Albers GW. Ann Neurol. 2006; 60 (3): 301-13
• Safety and tolerability of arundic acid in acute ischemic stroke. Pettigrew LC, Kasner SE, Albers GW, Gorman M, Grotta JC, Sherman DG, Funakoshi Y, Ishibashi H. J Neurol Sci. 2006; 251 (1-2): 50-6
• Trials and tribulations of noninferiority: the ximelagatran experience. Albers GW, Diener HC, Frison L, Grind M, Horrow J, Nevinson M, Olsson SB, Partridge S, Petersen P, Vahanian A, Halperin JL. J Am Coll Cardiol. 2006; 48 (5): 1058; author reply 1059
• Clinical importance of microbleeds in patients receiving IV thrombolysis. Kakuda W, Thijs VN, Lansberg MG, Bammer R, Wechsler L, Kemp S, Moseley ME, Marks MP, Albers GW. Neurology. 2005; 65 (8): 1175-8
• Enhancing the development and approval of acute stroke therapies: Stroke Therapy Academic Industry roundtable. Fisher M, Albers GW, Donnan GA, Furlan AJ, Grotta JC, Kidwell CS, Sacco RL, Wechsler LR. Stroke. 2005; 36 (8): 1808-13
• Intracranial angioplasty without stenting for symptomatic atherosclerotic stenosis: long-term follow-up. Marks MP, Marcellus ML, Do HM, Schraedley-Desmond PK, Steinberg GK, Tong DC, Albers GW. AJNR Am J Neuroradiol. 2005; 26 (3): 525-30
• Mechanical thrombectomy following intravenous thrombolysis in the treatment of acute stroke. Lansberg MG, Fields JD, Albers GW, Jayaraman MV, Do HM, Marks MP. Arch Neurol. 2005; 62 (11): 1763-5
• Mechanical thrombectomy for acute stroke. Versnick EJ, Do HM, Albers GW, Tong DC, Marks MP. AJNR Am J Neuroradiol. 2005; 26 (4): 875-9
• Oral antiplatelet therapy. Bernstein RA, Albers GW. JAMA. 2005; 293 (7): 793-4; author reply 794-5
• The Desmoteplase in Acute Ischemic Stroke Trial (DIAS): a phase II MRI-based 9-hour window acute stroke thrombolysis trial with intravenous desmoteplase. Hacke W, Albers G, Al-Rawi Y, Bogousslavsky J, Davalos A, Eliasziw M, Fischer M, Furlan A, Kaste M, Lees KR, Soehngen M, Warach S. Stroke. 2005; 36 (1): 66-73
• Ximelagatran vs warfarin for stroke prevention in patients with nonvalvular atrial fibrillation: a randomized trial. Albers GW, Diener HC, Frison L, Grind M, Nevinson M, Partridge S, Halperin JL, Horrow J, Olsson SB, Petersen P, Vahanian A. JAMA. 2005; 293 (6): 690-8
• A review of published TIA treatment recommendations. Albers GW, Neurology. 2004; 62 (8 Suppl 6): S26-8
• Antithrombotic and thrombolytic therapy for ischemic stroke: the Seventh ACCP Conference on Antithrombotic and Thrombolytic Therapy. Albers GW, Amarenco P, Easton JD, Sacco RL, Teal P. Chest. 2004; 126 (3 Suppl): 483S-512S
• Antithrombotic therapy in atrial fibrillation: the Seventh ACCP Conference on Antithrombotic and Thrombolytic Therapy. Singer DE, Albers GW, Dalen JE, Go AS, Halperin JL, Manning WJ. Chest. 2004; 126 (3 Suppl): 429S-456S
• Association of outcome with early stroke treatment: pooled analysis of ATLANTIS, ECASS, and NINDS rt-PA stroke trials. Hacke W, Donnan G, Fieschi C, Kaste M, von Kummer R, Broderick JP, Brott T, Frankel M, Grotta JC, Haley EC, Kwiatkowski T, Levine SR, Lewandowski C, Lu M, Lyden P, Marler JR, Patel S, Tilley BC, Albers G, Bluhmki E, Wilhelm M, Hamilton S. Lancet. 2004; 363 (9411): 768-74
• Comparing the guidelines: anticoagulation therapy to optimize stroke prevention in patients with atrial fibrillation. Rockson SG, Albers GW. J Am Coll Cardiol. 2004; 43 (6): 929-35
• Diffusion-weighted MR imaging in acute ischemia: value of apparent diffusion coefficient and signal intensity thresholds in predicting tissue at risk and final infarct size. Na DG, Thijs VN, Albers GW, Moseley ME, Marks MP. AJNR Am J Neuroradiol. 2004; 25 (8): 1331-6
• Discussion: Reconsideration of TIA terminology and definitions. Easton JD, Albers GW, Caplan LR, Saver JL, Sherman DG. Neurology. 2004; 62 (8 Suppl 6): S29-34
• Influence of arterial input function on hypoperfusion volumes measured with perfusion-weighted imaging. Thijs VN, Somford DM, Bammer R, Robberecht W, Moseley ME, Albers GW. Stroke. 2004; 35 (1): 94-8
• Optimizing oral anticoagulation in managed care. Caro JJ, Albers GW. Am J Manag Care. 2004; 10 (14 Suppl): S474-7
• Proceedings of the Seventh ACCP Conference on Antithrombotic and Thrombolytic Therapy: evidence-based guidelines. Chest. 2004; 126 (3 Suppl): 172S-696S
• Stroke prevention in atrial fibrillation: pooled analysis of SPORTIF III and V trials. Albers GW, Am J Manag Care. 2004; 10 (14 Suppl): S462-9; discussion S469-73
• Spinal manipulative therapy is an independent risk factor for vertebral artery dissection. Smith WS, Johnston SC, Skalabrin EJ, Weaver M, Azari P, Albers GW, Gress DR. Neurology. 2003; 60 (9): 1424-8
• ATLANTIS trial: results for patients treated within 3 hours of stroke onset. Alteplase Thrombolysis for Acute Noninterventional Therapy in Ischemic Stroke. Albers GW, Clark WM, Madden KP, Hamilton SA. Stroke. 2002; 33 (2): 493-5
• Clinical and radiological correlates of reduced cerebral blood flow measured using magnetic resonance imaging. Thijs VN, Adami A, Neumann-Haefelin T, Moseley ME, Albers GW. Arch Neurol. 2002; 59 (2): 233-8
• Patient safety in trials of therapy for acute ischemic stroke. Goldstein LB, Albers GW. JAMA. 2002; 287 (8): 987
• Transient ischemic attack--proposal for a new definition. Albers GW, Caplan LR, Easton JD, Fayad PB, Mohr JP, Saver JL, Sherman DG. N Engl J Med. 2002; 347 (21): 1713-6
• A comparison of warfarin and aspirin for the prevention of recurrent ischemic stroke. Mohr JP, Thompson JL, Lazar RM, Levin B, Sacco RL, Furie KL, Kistler JP, Albers GW, Pettigrew LC, Adams HP, Jackson CM, Pullicino P. N Engl J Med. 2001; 345 (20): 1444-51
• Advances in intravenous thrombolytic therapy for treatment of acute stroke. Albers GW, Neurology. 2001; 57 (5 Suppl 2): S77-81
• Antithrombotic and thrombolytic therapy for ischemic stroke. Albers GW, Amarenco P, Easton JD, Sacco RL, Teal P. Chest. 2001; 119 (1 Suppl): 300S-320S
• Antithrombotic therapy for prevention and treatment of ischemic stroke. Albers GW, J Thromb Thrombolysis. 2001; 12 (1): 19-22
• Antithrombotic therapy in atrial fibrillation. Albers GW, Dalen JE, Laupacis A, Manning WJ, Petersen P, Singer DE. Chest. 2001; 119 (1 Suppl): 194S-206S
• Aptiganel hydrochloride in acute ischemic stroke: a randomized controlled trial. Albers GW, Goldstein LB, Hall D, Lesko LM. JAMA. 2001; 286 (21): 2673-82
• Combination therapy with clopidogrel and aspirin: can the CURE results be extrapolated to cerebrovascula patients? Albers GW, Amarenco P. Stroke. 2001; 32 (12): 2948-9
• Evolution of apparent diffusion coefficient, diffusion-weighted, and T2-weighted signal intensity of acute stroke. Lansberg MG, Thijs VN, O'Brien MW, Ali JO, de Crespigny AJ, Tong DC, Moseley ME, Albers GW. AJNR Am J Neuroradiol. 2001; 22 (4): 637-44
• Evolution of cerebral infarct volume assessed by diffusion-weighted magnetic resonance imaging. Lansberg MG, O'Brien MW, Tong DC, Moseley ME, Albers GW. Arch Neurol. 2001; 58 (4): 613-7
• Hyperperfusion syndrome with hemorrhage after angioplasty for middle cerebral artery stenosis. Liu AY, Do HM, Albers GW, Lopez JR, Steinberg GK, Marks MP. AJNR Am J Neuroradiol. 2001; 22 (8): 1597-601
• Potential utility of diffusion-weighted imaging in venous infarction. Bernstein R, Albers GW. Arch Neurol. 2001; 58 (10): 1538-9
• Relationship between severity of MR perfusion deficit and DWI lesion evolution. Thijs VN, Adami A, Neumann-Haefelin T, Moseley ME, Marks MP, Albers GW. Neurology. 2001; 57 (7): 1205-11
• Recent advances in stroke management. Albers GW, Alberts MJ, Broderick JP, Lyden PD, Sacco RL. J Stroke Cerebrovasc Dis. 2000 May-Jun; 9 (3): 95-105
• Basilar artery stenosis: clinical and neuroradiographic features. Woolfenden AR, Tong DC, Norbash AM, Ali AO, Marks MP, O'Brien MW, Albers GW. J Stroke Cerebrovasc Dis. 2000 Mar-Apr; 9 (2): 57-63
• Cardioembolic vs. noncardioembolic strokes in atrial fibrillation: frequency and effect of antithrombotic agents in the stroke prevention in atrial fibrillation studies. Hart RG, Pearce LA, Miller VT, Anderson DC, Rothrock JF, Albers GW, Nasco E. Cerebrovasc Dis. 2000 Jan-Feb; 10 (1): 39-43
• Addendum to the supplement to the guidelines for the management of transient ischemic attacks Albers GW, Hart RG, Lutsep HL, Newell DW, Sacco RL. Stroke. 2000; 31 (4): 1001
• Advantages of adding diffusion-weighted magnetic resonance imaging to conventional magnetic resonance imaging for evaluating acute stroke. Lansberg MG, Norbash AM, Marks MP, Tong DC, Moseley ME, Albers GW. Arch Neurol. 2000; 57 (9): 1311-6
• Choice of endpoints in antiplatelet trials: which outcomes are most relevant to stroke patients? Albers GW, Neurology. 2000; 54 (5): 1022-8
• Clinical problem-solving. Eyes wide open. Morton-Bours EC, Jacobs MB, Albers GW. N Engl J Med. 2000; 343 (1): 50-5
• Comparison of diffusion-weighted MRI and CT in acute stroke. Lansberg MG, Albers GW, Beaulieu C, Marks MP. Neurology. 2000; 54 (8): 1557-61
• Diffusion and perfusion magnetic resonance imaging for the evaluation of acute stroke: potential use in guiding thrombolytic therapy. Tong DC, Albers GW. Curr Opin Neurol. 2000; 13 (1): 45-50
• Intravenous tissue-type plasminogen activator for treatment of acute stroke: the Standard Treatment with Alteplase to Reverse Stroke (STARS) study. Albers GW, Bates VE, Clark WM, Bell R, Verro P, Hamilton SA. JAMA. 2000; 283 (9): 1145-50
• Is early ischemic lesion volume on diffusion-weighted imaging an independent predictor of stroke outcome? A multivariable analysis. Thijs VN, Lansberg MG, Beaulieu C, Marks MP, Moseley ME, Albers GW. Stroke. 2000; 31 (11): 2597-602
• New magnetic resonance imaging methods for cerebrovascular disease: emerging clinical applications. Neumann-Haefelin T, Moseley ME, Albers GW. Ann Neurol. 2000; 47 (5): 559-70
• Selfotel in acute ischemic stroke : possible neurotoxic effects of an NMDA antagonist. Davis SM, Lees KR, Albers GW, Diener HC, Markabi S, Karlsson G, Norris J. Stroke. 2000; 31 (2): 347-54
• Supplement to the AHA guidelines for the management of transient ischemic attacks Hughes RL, Albers GW, Hart RG, Lutsep HL, Newell DW, Sacco RL. Stroke. 2000; 31 (4): 983-91
• Symptomatic intracranial atherosclerosis: outcome of patients who fail antithrombotic therapy. Thijs VN, Albers GW. Neurology. 2000; 55 (4): 490-7
• The rtPA (alteplase) 0- to 6-hour acute stroke trial, part A (A0276g) : results of a double-blind, placebo-controlled, multicenter study. Thromblytic therapy in acute ischemic stroke study investigators. Clark WM, Albers GW, Madden KP, Hamilton S. Stroke. 2000; 31 (4): 811-6
• Yield of diffusion-weighted MRI for detection of potentially relevant findings in stroke patients. Albers GW, Lansberg MG, Norbash AM, Tong DC, O'Brien MW, Woolfenden AR, Marks MP, Moseley ME. Neurology. 2000; 54 (8): 1562-7
• Headache with neurological deficits and CSF lymphocytosis: A transient ischemic attack mimic. Lansberg MG, Woolfenden AR, Norbash AM, Smith DB, Albers GW. J Stroke Cerebrovasc Dis. 1999 Jan-Feb; 8 (1): 42-4
• A standardized MRI stroke protocol: comparison with CT in hyperacute intracerebral hemorrhage. Tong DC, Albers GW, Yenari MA, Marks MP. Stroke. 1999; 30 (9): 1974-5
• AHA Scientific Statement. Supplement to the guidelines for the management of transient ischemic attacks: A statement from the Ad Hoc Committee on Guidelines for the Management of Transient Ischemic Attacks, Stroke Council, American Heart Association. Albers GW, Hart RG, Lutsep HL, Newell DW, Sacco RL. Stroke. 1999; 30 (11): 2502-11
• Acute Ischemic Stroke. Chan BP, Albers GW. Curr Treat Options Neurol. 1999; 1 (2): 83-96
• Antiplatelet therapy: new foundations for optimal treatment decisions. Albers GW, Tijssen JG. Neurology. 1999; 53 (7 Suppl 4): S25-31
• Antithrombotic management of atrial fibrillation for stroke prevention in older people. Tong DC, Albers GW. Clin Geriatr Med. 1999; 15 (4): 645-62
• Applications of diffusion-perfusion magnetic resonance imaging in acute ischemic stroke. Fisher M, Albers GW. Neurology. 1999; 52 (9): 1750-6
• Cerebral amyloid angiopathy with unilateral hemorrhages, mass effect, and meningeal enhancement. Morton-Bours EC, Skalabrin EJ, Albers GW. Neurology. 1999; 53 (1): 233-4
• Dose escalation study of the NMDA glycine-site antagonist licostinel in acute ischemic stroke. Albers GW, Clark WM, Atkinson RP, Madden K, Data JL, Whitehouse MJ. Stroke. 1999; 30 (3): 508-13
• Emerging evidence for inflammation in conditions frequently affecting older adults: report of a symposium. Hamerman D, Berman JW, Albers GW, Brown DL, Silver D. J Am Geriatr Soc. 1999; 47 (8): 1016-25
• Evaluation of early reperfusion and i.v. tPA therapy using diffusion- and perfusion-weighted MRI. Marks MP, Tong DC, Beaulieu C, Albers GW, de Crespigny A, Moseley ME. Neurology. 1999; 52 (9): 1792-8
• Expanding the window for thrombolytic therapy in acute stroke. The potential role of acute MRI for patient selection. Albers GW, Stroke. 1999; 30 (10): 2230-7
• Longitudinal magnetic resonance imaging study of perfusion and diffusion in stroke: evolution of lesion volume and correlation with clinical outcome. Beaulieu C, de Crespigny A, Tong DC, Moseley ME, Albers GW, Marks MP. Ann Neurol. 1999; 46 (4): 568-78
• MRI abnormalities associated with partial status epilepticus. Lansberg MG, O'Brien MW, Norbash AM, Moseley ME, Morrell M, Albers GW. Neurology. 1999; 52 (5): 1021-7
• Moyamoya syndrome in children with Alagille syndrome: additional evidence of a vasculopathy. Woolfenden AR, Albers GW, Steinberg GK, Hahn JS, Johnston DC, Farrell K. Pediatrics. 1999; 103 (2): 505-8
• Outcome of angioplasty for atherosclerotic intracranial stenosis. Marks MP, Marcellus M, Norbash AM, Steinberg GK, Tong D, Albers GW. Stroke. 1999; 30 (5): 1065-9
• Recombinant tissue-type plasminogen activator (Alteplase) for ischemic stroke 3 to 5 hours after symptom onset. The ATLANTIS Study: a randomized controlled trial. Alteplase Thrombolysis for Acute Noninterventional Therapy in Ischemic Stroke. Clark WM, Wissman S, Albers GW, Jhamandas JH, Madden KP, Hamilton S. JAMA. 1999; 282 (21): 2019-26
• Risk factors for stroke and primary prevention of stroke in atrial fibrillation. Laupacis A, Singer D, Jacobsen A, Dunn M, Dalen J, Albers G. J Thromb Thrombolysis. 1999; 7 (1): 21-6
• Thrombolysis with reteplase, an unglycosylated plasminogen activator variant, in experimental embolic stroke. Yenari MA, Lee LK, Beaulieu C, Sun GH, Kunis D, Chang D, Albers GW, Moseley ME, Steinberg GK. J Stroke Cerebrovasc Dis. 1998 May-Jun; 7 (3): 179-86
• Angiographically defined primary angiitis of the CNS: is it really benign? Woolfenden AR, Tong DC, Marks MP, Ali AO, Albers GW. Neurology. 1998; 51 (1): 183-8
• Antithrombotic and thrombolytic therapy for ischemic stroke. Albers GW, Easton JD, Sacco RL, Teal P. Chest. 1998; 114 (5 Suppl): 683S-698S
• Antithrombotic therapy in atrial fibrillation. Laupacis A, Albers G, Dalen J, Dunn MI, Jacobson AK, Singer DE. Chest. 1998; 114 (5 Suppl): 579S-589S
• Choice of antithrombotic therapy for stroke prevention in atrial fibrillation: warfarin, aspirin, or both? Albers GW, Arch Intern Med. 1998; 158 (14): 1487-91
• Correlation of perfusion- and diffusion-weighted MRI with NIHSS score in acute (<6.5 hour) ischemic stroke. Tong DC, Yenari MA, Albers GW, O'Brien M, Marks MP, Moseley ME. Neurology. 1998; 50 (4): 864-70
• Diffusion-weighted MRI for evaluation of acute stroke. Albers GW, Neurology. 1998; 51 (3 Suppl 3): S47-9
• Ethical standards in phase 1 trials of neuroprotective agents for stroke therapy. Albers GW, Zivin JA, Choi DW. Stroke. 1998; 29 (8): 1493-4
• Progressive facial hemiatrophy: abnormality of intracranial vasculature. Woolfenden AR, Tong DC, Norbash AM, Albers GW. Neurology. 1998; 50 (6): 1915-7
• American Heart Association Prevention Conference. IV. Prevention and Rehabilitation of Stroke. Etiology of stroke. Mohr JP, Albers GW, Amarenco P, Babikian VL, Biller J, Brey RL, Coull B, Easton JD, Gomez CR, Helgason CM, Kase CS, Pullicino PM, Turpie AG. Stroke. 1997; 28 (7): 1501-6
• Clinical characteristics and management of acute stroke in patients with atrial fibrillation admitted to US university hospitals. Albers GW, Bittar N, Young L, Hattemer CR, Gandhi AJ, Kemp SM, Hall EA, Morton DJ, Yim J, Vlasses PH. Neurology. 1997; 48 (6): 1598-604
• Clinical utility of diffusion-weighted magnetic resonance imaging in the assessment of ischemic stroke. Lutsep HL, Albers GW, DeCrespigny A, Kamat GN, Marks MP, Moseley ME. Ann Neurol. 1997; 41 (5): 574-80
• Improved perfusion with rt-PA and hirulog in a rabbit model of embolic stroke. Yenari MA, de Crespigny A, Palmer JT, Roberts S, Schrier SL, Albers GW, Moseley ME, Steinberg GK. J Cereb Blood Flow Metab. 1997; 17 (4): 401-11
• Intravenous thrombolytic therapy in acute stroke. Tong DC, Yenari MA, Albers GW. Vasc Med. 1997; 2 (1): 51-60
• Management of acute ischemic stroke. An update for primary care physicians. Albers GW, West J Med. 1997; 166 (4): 253-62
• Rationale for early intervention in acute stroke. Albers GW, Am J Cardiol. 1997; 80 (4C): 4D-10D; discussion 35D-39D
• Termination of Acute Stroke Studies Involving Selfotel Treatment. ASSIST Steering Committed. Davis SM, Albers GW, Diener HC, Lees KR, Norris J. Lancet. 1997; 349 (9044): 32
• Use of fluid attenuating inversion recovery, MR angiogram, and diffusion-weighted MRI techniques for assessment of pontine infarction in a patient treated with radiation therapy for pituitary neoplasm. Graef LM, Lutsep HL, Norbash A, Albers GW. Neurology. 1997; 48 (2): 540-2
• Acute and chronic stroke: navigated spin-echo diffusion-weighted MR imaging. Marks MP, de Crespigny A, Lentz D, Enzmann DR, Albers GW, Moseley ME. Radiology. 1996; 199 (2): 403-8
• Anticoagulant therapy monitoring with international normalized ratio at US academic health centers. Yim JM, Albers GW, Vlasses PH. Ann Pharmacother. 1996; 30 (12): 1390-5
• MELAS: Clinical and pathologic correlations with MRI, xenon/CT, and MR spectroscopy. Clark JM, Marks MP, Adalsteinsson E, Spielman DM, Shuster D, Horoupian D, Albers GW. Neurology. 1996; 46 (1): 223-7
• MR and cerebrospinal fluid enzymes as sensitive indicators of subclinical cerebral injury after open-heart valve replacement surgery. Steinberg GK, De La Paz R, Mitchell RS, Bell TE, Albers GW. AJNR Am J Neuroradiol. 1996; 17 (2): 205-12; discussion 213-5
• Safety of heparin in acute ischemic stroke. Hart RG, Boop BS, Tong DC, Yenari MA, Albers GW. Neurology. 1996; 46 (2): 589; author reply 589-91
• Status of antithrombotic therapy for patients with atrial fibrillation in university hospitals. Albers GW, Yim JM, Belew KM, Bittar N, Hattemer CR, Phillips BG, Kemp S, Hall EA, Morton DJ, Vlasses PH. Arch Intern Med. 1996; 156 (20): 2311-6
• Anticoagulation/platelet inhibition for atrial fibrillation. Albers GW, Hirsh J. Coron Artery Dis. 1995; 6 (2): 129-35
• Antithrombotic agents in cerebral ischemia. Albers GW, Am J Cardiol. 1995; 75 (6): 34B-38B
• Antithrombotic therapy in atrial fibrillation. Laupacis A, Albers G, Dalen J, Dunn M, Feinberg W, Jacobson A. Chest. 1995; 108 (4 Suppl): 352S-359S
• Cost-effectiveness of warfarin and aspirin for prophylaxis of stroke in patients with nonvalvular atrial fibrillation. Gage BF, Cardinalli AB, Albers GW, Owens DK. JAMA. 1995; 274 (23): 1839-45
• Detection of carotid stenosis. From NASCET results to clinical practice. Chang YJ, Golby AJ, Albers GW. Stroke. 1995; 26 (8): 1325-8
• Neurologic complications following chiropractic manipulation: a survey of California neurologists. Lee KP, Carlini WG, McCormick GF, Albers GW. Neurology. 1995; 45 (6): 1213-5
• Safety, tolerability, and pharmacokinetics of the N-methyl-D-aspartate antagonist dextrorphan in patients with acute stroke. Dextrorphan Study Group. Albers GW, Atkinson RP, Kelley RE, Rosenbaum DM. Stroke. 1995; 26 (2): 254-8
• Transcranial Doppler-detected microemboli in patients with acute stroke. Tong DC, Albers GW. Stroke. 1995; 26 (9): 1588-92
• Vertical gaze palsies from medial thalamic infarctions without midbrain involvement. Clark JM, Albers GW. Stroke. 1995; 26 (8): 1467-70
• Atrial fibrillation and stroke. Three new studies, three remaining questions. Albers GW, Arch Intern Med. 1994; 154 (13): 1443-8
• Guidelines for the management of transient ischemic attacks. From the Ad Hoc Committee on Guidelines for the Management of Transient Ischemic Attacks of the Stroke Council of the American Heart Association. Feinberg WM, Albers GW, Barnett HJ, Biller J, Caplan LR, Carter LP, Hart RG, Hobson RW, Kronmal RA, Moore WS. Circulation. 1994; 89 (6): 2950-65
• Incidence of transcranial Doppler-detected cerebral microemboli in patients referred for echocardiography. Tong DC, Bolger A, Albers GW. Stroke. 1994; 25 (11): 2138-41
• Transesophageal echocardiographic findings in stroke subtypes. Albers GW, Comess KA, DeRook FA, Bracci P, Atwood JE, Bolger A, Hotson J. Stroke. 1994; 25 (1): 23-8
• Transesophageal echocardiography and carotid ultrasound in patients with cerebral ischemia: prevalence of findings and recurrent stroke risk. Comess KA, DeRook FA, Beach KW, Lytle NJ, Golby AJ, Albers GW. J Am Coll Cardiol. 1994; 23 (7): 1598-603
• Anticoagulation and atrial fibrillation. Atwood JE, Albers GW. Herz. 1993; 18 (1): 27-38
• Laboratory monitoring of oral anticoagulant therapy: are we being misled? Albers GW, Neurology. 1993; 43 (3 Pt 1): 468-70
• Antithrombotic therapy in atrial fibrillation. Laupacis A, Albers G, Dunn M, Feinberg W. Chest. 1992; 102 (4 Suppl): 426S-433S
• Do NMDA antagonists prevent neuronal injury? Yes. Albers GW, Goldberg MP, Choi DW. Arch Neurol. 1992; 49 (4): 418-20
• Failure of high-dose heparin to prevent recurrent cardioembolic strokes in a pregnant patient with a mechanical heart valve. Golby AJ, Bush EC, DeRook FA, Albers GW. Neurology. 1992; 42 (11): 2204-6
• Recurrent transverse myelitis, myasthenia gravis, and autoantibodies. Lindsey JW, Albers GW, Steinman L. Ann Neurol. 1992; 32 (3): 407-9
• Role of ticlopidine for prevention of stroke. Albers GW, Stroke. 1992; 23 (6): 912-6
• Tolerability of oral dextromethorphan in patients with a history of brain ischemia. Albers GW, Sáenz RE, Moses JA. Clin Neuropharmacol. 1992; 15 (6): 509-14
• Transesophageal echocardiography in the evaluation of stroke. DeRook FA, Comess KA, Albers GW, Popp RL. Ann Intern Med. 1992; 117 (11): 922-32
• Treatment of tardive dyskinesia with vitamin E. Egan MF, Hyde TM, Albers GW, Elkashef A, Alexander RC, Reeve A, Blum A, Saenz RE, Wyatt RJ. Am J Psychiatry. 1992; 149 (6): 773-7
• Lacunar stroke: relationship between atypical etiology and infarct size? Albers GW, Arch Neurol. 1991; 48 (12): 1215
• Safety and tolerance of oral dextromethorphan in patients at risk for brain ischemia. Albers GW, Sáenz RE, Moses JA, Choi DW. Stroke. 1991; 22 (8): 1075-7
• Stroke prevention in nonvalvular atrial fibrillation. Albers GW, Atwood JE, Hirsh J, Sherman DG, Hughes RA, Connolly SJ. Ann Intern Med. 1991; 115 (9): 727-36
• Stroke prevention in nonvalvular atrial fibrillation: a review of prospective randomized trials. Albers GW, Sherman DG, Gress DR, Paulseth JE, Petersen P. Ann Neurol. 1991; 30 (4): 511-8
• Intensity of anticoagulant treatment and risk of intracerebral hematoma. Albers GW, Stroke. 1990; 21 (12): 1758
• Potential therapeutic uses of N-methyl-D-aspartate antagonists in cerebral ischemia. Albers GW, Clin Neuropharmacol. 1990; 13 (3): 177-97
• N-methyl-D-aspartate antagonists: ready for clinical trial in brain ischemia? Albers GW, Goldberg MP, Choi DW. Ann Neurol. 1989; 25 (4): 398-403
• Nifedipine versus propranolol for the initial prophylaxis of migraine. Albers GW, Simon LT, Hamik A, Peroutka SJ. Headache. 1989; 29 (4): 215-8
• Treatment response in malignant optic glioma of adulthood. Albers GW, Hoyt WF, Forno LS, Shratter LA. Neurology. 1988; 38 (7): 1071-4
• Left ventricular tumor masquerading as multiple sclerosis. Albers GW, Avalos SM, Weinrich M. Arch Neurol. 1987; 44 (7): 779-80
• Calcium chloride for treatment of subcutaneous lipomas in dogs. Albers GW, Theilen GH. J Am Vet Med Assoc. 1985; 186 (5): 492-4